EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa



U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa



Journal of Clinical Microbiology 36(3): 708-715



A case is reported in a 36-year-old man originally from Saudi Arabia, who presented in Pennsylvania, USA, in 1995 with a 2-week history of right-hand weakness which worsened to involve the entire upper extremity. On the day prior to his admission, the patient had a focal motor seizure with rotation of the head and eyes to the right, followed by secondary generalization.

(PDF 0-2 workdays service: $29.90)

Accession: 003325435

Download citation: RISBibTeXText

PMID: 9508300



Related references

Cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (Ramichloridium mackenziei): case report. Neurosurgery 45(2): 372-375, 1999

SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei"). Antimicrobial Agents and ChemoTherapy 44(5): 1159-1162, 2000

Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. Journal of Infection and Public Health 4(2): 96-102, 2011

Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): a taxonomic update and review of the literature. Medical Mycology 48(3): 546-556, 2010

A case of cerebral phaeohyphomycosis caused by Fonsecaea monophora, a neurotropic dematiaceous fungus, and a review of the literature. Mycoses 58(3): 187-192, 2015

Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei in the Eastern Province of Saudi Arabia. Annals of Saudi Medicine 20(5-6): 457-460, 2007

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Medical Mycology 43(1): 91-95, 2005

Additional case of Ramichloridium mackenziei cerebral phaeohyphomycosis from the Middle East. Medical Mycology 40(4): 429-433, 2002

Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei. Diagnostic Cytopathology 35(11): 695-699, 2007

Activity of SCH56592 , itraconazole , and amphotericin B in experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 470, 1998

Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries. Journal of Medical and Veterinary Mycology 31(4): 325-332, 1993

Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei, new species in middle eastern countries. Journal of Medical & Veterinary Mycology 31(4): 325-332, 1993

Fatal brain abscesses caused by Ramichloridium obovoideum: report of three cases. Acta Neurochirurgica 93(3-4): 92-95, 1988

Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A Case and Review. Mycoses, 2017

Ramichloridium mackenziei brain abscess: report of two cases and review of the literature. Medical Mycology 39(1): 97-102, 2001